Jump to content
Support our work - please give today

From journals and scientific sources

Primary sources for information and statistics.

371 topics in this forum

  1. Smith, 2007 Receptor occupancy of mirtazapine determined by PET in healthy volunteers.

    By Altostrata,
    • 0 replies
    • 989 views

  2. CDC, 2014 Use of Medication Prescribed for Emotional or Behavioral Difficulties Among Children Aged 6–17 Years in the United States, 2011–2012

    By Altostrata,
    • 7 replies
    • 1.2k views

  3. Hadjikhani, 2010 Serotonin, pregnancy and increased autism prevalence: is there a link?

    By Altostrata,
    • 9 replies
    • 1.6k views

  4. Urichuk, 2008 Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.

    By Altostrata,
    • 0 replies
    • 791 views

  5. Haddad, 2011 Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.

    By Altostrata,
    • 0 replies
    • 856 views

  6. Leiblum, 2008 Persistent genital arousal disorder in women: case reports of association with anti-depressant usage and withdrawal.

    By Altostrata,   
    • 1 reply
    • 1.4k views

  7. Goldmeier, 2009 Persistent genital arousal disorder: a review of the literature and recommendations for management.

    By Altostrata,   
    • 0 replies
    • 965 views

  8. Wang, 2013 Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.

    By Altostrata,
    • 0 replies
    • 841 views

  9. Bottelier, 2014 The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.

    By Altostrata,
    • 1 reply
    • 838 views

  10. Mulder, 2013 Outcome of mood disorders before psychopharmacology: A systematic review.

    By Altostrata,
    • 1 reply
    • 972 views

  11. Markoula, 2010 Akathisia induced by mirtazapine after 20 years of continuous treatment.

    By Altostrata,
    • 0 replies
    • 967 views

  12. Read, 2014 Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants.

    By Altostrata,
    • 1 reply
    • 1.3k views

  13. Prescrire Int., 2013 Duloxetine: withdrawal syndromes.

    By Altostrata,
    • 0 replies
    • 1.4k views

  14. Skaehill, 1997 Clinical Reviews: SSRI Withdrawal Syndrome

    By Altostrata,
    • 1 reply
    • 3.8k views

  15. Schatzberg, 2006 Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional...

    By Altostrata,
    • 4 replies
    • 1.4k views

  16. Zajecka, 1997 Discontinuation symptoms after treatment with serotonin reuptake inhibitors

    By squirrel,
    • 1 reply
    • 882 views

  17. Schatzberg, 1997 Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.

    By Altostrata,
    • 4 replies
    • 1.2k views

  18. Wunderink, 2013 Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy...

    By Altostrata,
    • 3 replies
    • 1.3k views

  19. Guaiana, 2013 Agomelatine versus other antidepressive agents for major depression.

    By Altostrata,
    • 0 replies
    • 831 views

  20. Shelton, 2001 Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy

    By Altostrata,
    • 9 replies
    • 2.3k views

  21. Shelton, 2006 The nature of the discontinuation syndrome associated with antidepressant drugs

    By Altostrata,
    • 12 replies
    • 4k views

  22. Padala, 2012 Reversal of SSRI-associated apathy syndrome by discontinuation of therapy.

    By Altostrata,
    • 4 replies
    • 1.2k views

  23. Coupland, 2011 Antidepressant use and risk of adverse outcomes in older people

    By Gem,
    • 2 replies
    • 1.5k views

  24. Fabian, 2004 Paroxetine-induced hyponatremia in older adults: a 12-week prospective study.

    By Altostrata,
    • 1 reply
    • 1.1k views

  25. Stevenson, 2013 Serotonin syndrome associated with clozapine withdrawal.

    By Altostrata,
    • 0 replies
    • 1.2k views

  26. Emiliano, 2004 From Galactorrhea to Osteopenia: Rethinking Serotonin - Prolactin Interactions

    By Barbarannamated,
    • 1 reply
    • 793 views

  27. Bohlega, 2013 Drug-induced Parkinson`s disease. A clinical review.

    By Altostrata,
    • 0 replies
    • 673 views

  28. Tonks, 2002 Withdrawal from paroxetine can be severe, warns FDA

    By Altostrata,
    • 3 replies
    • 1.6k views

  29. Herzallah, 2013 Learning from Negative Feedback in Patients with Major Depressive Disorder is Attenuated by SSRI Antidepressants

    By Altostrata,
    • 5 replies
    • 980 views

  30. Longo, 2000 Addiction: Part I. Benzodiazepines—Side Effects, Abuse Risk and Alternatives

    By Altostrata,
    • 0 replies
    • 1.4k views

  31. Kast, 2009 Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone.

    By Altostrata,
    • 4 replies
    • 2.2k views

  32. Cameron, 2013 Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care.

    By Altostrata,
    • 3 replies
    • 757 views

  33. Werremeyer, 2013 Retrospective review of a case of serotonin syndrome after discontinuation of risperidone

    By Barbarannamated,
    • 2 replies
    • 727 views

  34. Prakash, 2013 Headache as a presenting feature in patients with serotonin syndrome: A case series.

    By Altostrata,
    • 2 replies
    • 834 views

  35. Pogliani, 2010 Paroxetine and neonatal withdrawal syndrome.

    By Altostrata,
    • 1 reply
    • 790 views

  36. 2013, Harvard Institutional Corruption and Pharmaceutical Policy Symposium

    By Rhiannon,
    • 1 reply
    • 723 views
×
×
  • Create New...

Important Information

Terms of Use Privacy Policy

  I accept